Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Nandrolone Decanoate MeSH Descriptor Data 2026


MeSH Heading
Nandrolone Decanoate
Tree Number(s)
D04.210.500.365.415.638.500
D06.472.334.851.968.976.500
Unique ID
D000077603
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077603
Scope Note
Decanoic acid ester of nandrolone that is used as an anabolic agent to prevent or treat WASTING SYNDROME associated with severe chronic illness or HIV infection (HIV WASTING SYNDROME). It may also be used in the treatment of POSTMENOPAUSAL OSTEOPOROSIS.
Entry Term(s)
17 beta-Hydroxyestr-4-en-3-one 17-decanoate
19-Nortestosterone Decanoate
19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate
Decadurabolin
Decadurobolin
Retabolil
Retabolyl
Pharm Action
Anabolic Agents
Bone Density Conservation Agents
Registry Numbers
H45187T098
0
Related Numbers
360-70-3
Public MeSH Note
2019; NANDROLONE DECANOATE was indexed under NANDROLONE/ analogs & derivatives 1971-2018
History Note
2019 (1971)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Nandrolone Decanoate Preferred
Retabolil Narrower
Decadurabolin Narrower
19-Nortestosterone Decanoate Related
19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate Related
page delivered in 0.139s